Skip to main content
Book cover

Glucagon II pp 537–543Cite as

Glucagon and Catecholamines

  • Chapter

Part of the book series: Handbook of Experimental Pharmacology ((HEP,volume 66 / 2))

Abstract

Glucagon and catecholamines share numerous metabolic effects. In addition, catecholamines are potent stimulators of glucagon secretion and, under certain conditions, glucagon stimulates catecholamine release from the adrenal medulla. Finally, the involvement of catecholamines has been invoked to explain some of the metabolic actions of glucagon. The stimulation of glucagon release by catecholamines has been reviewed in detail in Chap. 30 while the possible involvement of catecholamines in some effects of glucagon has been considered in Chaps. 37 and 38. In this short contribution, we will summarize the in vitro and in vivo studies dealing with the effects of glucagon on catecholamine release and review the potential of these findings for the diagnosis of pheochromocytoma.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Beggs I (1978) Pheochromocytoma diagnosed during barium meal. Br J Radiol 51: 918

    Article  PubMed  CAS  Google Scholar 

  • Bernheim C, Jaillon P, Graisely B, Cloarec M, Debray J, Cheymol G (1978) Diagnostic d’un pheochromocytome par dosage des catecholamines plasmatiques au cours du test au glucagon. Nouv Presse Med 7: 553–555

    PubMed  CAS  Google Scholar 

  • Cession-Fossion A, Lecomte J, Lefebvre P (1966) Sur la stimulation medullo surrenalienne induite chez le rat par le glucagon. CR Soc Biol (Paris) 160: 723–726

    CAS  Google Scholar 

  • Cremer GM, Molnar GD, Moxness KE, Sheps SG, Maher FT, Jones JD (1968) Hormonal and biochemical response to glucagon administration in patients with pheochromocytoma and in control subjects. Mayo Clin Proc 43: 161–176

    PubMed  CAS  Google Scholar 

  • Dexter RN, Allen DO (1970) A glucagon–sensitive adenylcyclase system in pheochromocytoma. Clin Res 18: 601

    Google Scholar 

  • Galloway JA (1972) The pharmacology and clinical use of glucagon. In: Lefebvre PJ, Unger RH (eds) Glucagon: molecular physiology, clinical and therapeutic implications. Pergamon, Oxford, p 299

    Google Scholar 

  • Geelhoed GW (1980) CAT scans and catecholamines. Surgery 87: 719–720

    PubMed  CAS  Google Scholar 

  • Hinterberger H, Wilcken DEL (1974) The effect of prolonged glucagon infusions on the urinary excretion of catecholamines and 3-hydroxy-3-methoxymandelic acid and on adrenal medullary tissue levels of catecholamines in patients with severe cardiac disease. Clin Chim Acta 52: 153–161

    Article  PubMed  CAS  Google Scholar 

  • Kitabchi AE, Solomon SS, Williams RH (1968) Stimulatory effect of insulin and glucagon on phenylethanolamine-TV-methyl transferase of rat adrenal. Proc Soc Exp Biol Med 127: 296–300

    PubMed  CAS  Google Scholar 

  • Kuchel O, Hamet P, Bun NT, Larochelle P (1981) Basis of falsepositive glucagon tests for pheochromocytoma. Clin Pharmacol Ther 29: 687–694

    Article  PubMed  CAS  Google Scholar 

  • Kuschke H J, Klusmann H, Schölkens B (1966 a) Über die Wirkung von Glucagon auf den Katecholamin-Plasmaspiegel beim Menschen. Arch Exp Pathol Pharmakol 253: 65

    Google Scholar 

  • Kuschke HJ, Klusmann N, Schölkens B (1966 b) Untersuchungen über die Wirkung von Glukagon auf des sympatho-adrenale System des Menschen. Klin Wochenschr 44: 1297–1300

    Article  PubMed  CAS  Google Scholar 

  • Lawrence AM (1965) A new provocative test for pheochromocytoma. Ann Intern Med 63: 905–906

    Google Scholar 

  • Lawrence AM (1967) Glucagon provocative test for pheochromocytoma. Ann Intern Med 66: 1091–1096

    PubMed  CAS  Google Scholar 

  • Lawrence AM, Forland M (1964) Glucagon provocative test for pheochromocytoma. J Lab Clin Med 64: 878

    Google Scholar 

  • Lefèbvre P, Dresse A (1961) Influence du glucagon sur le taux des catécholamines surréna liennes chez le rat. CR Soc Biol (Paris) 155: 412–414

    Google Scholar 

  • Lefèbvre PJ, Cession-Fossion A, Luyckx AS (1966) Glucagon test for pheochromocytoma. Lancet 2: 1366

    Article  Google Scholar 

  • Lefèbvre PJ, Cession-Fossion A, Luyckx AS, Lecomte J, Van Cauwenberge H (1968) Interrelationships glucagon-adrenergic system in experimental and clinical conditions. Arch Int Pharmacodyn 172: 393–404

    PubMed  Google Scholar 

  • Levey GS, Weiss SR, Ruiz E (1975) Characterization of the glucagon receptor in a pheochromocytoma. J Clin Endocrinol Metab 40: 720–723

    Article  PubMed  CAS  Google Scholar 

  • Llorens I, Borrell J, Borrell S (1973) Effects of insulin, glucagon and adrenocorticotrophin on the levels of corticosteroids, noradrenaline, adrenaline and ascorbic acid in the adrenal glands of cat. Horm Res 4: 321–330

    Article  PubMed  CAS  Google Scholar 

  • Lupulescu A, Chivu V, Petrovici A (1966) Effect of aldosterone, glucagon and growth hormone on the catecholamine content and the evolution of chromaffin hyperplasia in guinea pigs. Experientia 22: 222–223

    Article  PubMed  CAS  Google Scholar 

  • Mandai T, Ogihara T, Hata T, Okada Y, Ogasahara S, Mikami H, Nakamaru M, Kumahara Y (1980) Urinary catecholamine response to glucagon in young and elderly patients with essential hypertension. J Am Geriatr Soc 28: 462–465

    PubMed  CAS  Google Scholar 

  • McLoughlin M, Langer B, Wilson DR (1981) Lifethreatening reaction to glucagon in a patient with pheochromocytoma. Radiology 140: 841–842

    PubMed  CAS  Google Scholar 

  • Roth RH, Stjarne L, Levine RJ, Giarman NJ (1968) Abnormal regulation of catecholamines synthesis in pheochromocytoma. J Lab Clin Med 72: 397–403

    PubMed  CAS  Google Scholar 

  • Sarcione EJ, Back N, Sokal JE, Mehlman B, Knoblock E (1963) Elevation of plasma epinephrine levels produced by glucagon in vivo. Endocrinology 72: 523–526

    Article  PubMed  CAS  Google Scholar 

  • Scian LF, Westermann CD, Verdesca AS, Hilton JG (1960) Adrenocortical and medullary effects of glucagon, Am J Physiol 199: 867–870

    PubMed  CAS  Google Scholar 

  • Schoor I, Hinshaw HT, Cooper MA, Mahaffee D, Ney RL (1972) Adenylcyclase hormone responses of certain human endocrine tumors. J Clin Endocrinol Metab 34: 447–451

    Article  Google Scholar 

  • Sebel EF, Hull RD, Kleerekoper M, Stokes GS (1974) Response to glucagon in hypertensive patients with and without pheochromocytoma. Am J Med Sci 267: 337–343

    Article  PubMed  CAS  Google Scholar 

  • Sheps SG, Maher FT (1968) Histamine and glucagon tests in diagnosis of pheochromocytoma. JAMA 205: 895–899

    Article  PubMed  CAS  Google Scholar 

  • Simard S J (1974) Valeur diagnostique des catécholamines plasmatiques dans le test au glucagon pour le phéochromocytome. Union Med Can 103: 460–465

    PubMed  CAS  Google Scholar 

  • Siqueira-Filho AG, Sheps SG, Maher FT, Nai Siang J, Elveback LR (1975) Glucagon blood catecholamine test. Arch Intern Med 135: 1227–1231

    Article  Google Scholar 

  • Uda M, Sakamoto N, Tsuchiya M, Ito K, Ikeda M, Matsukura S, Fujita T (1982) Responses of plasma catecholamine and plasma renin activity after glucagon stimulation in essential hypertension. Acta Endocr 101: 242–247

    PubMed  CAS  Google Scholar 

  • Wahlen Ch, Appeltants A, Limet R (1983) Neurofibromatose et phéochromocytome.Histoire d’un cas. Rev. Med. Liege 38: 56–57

    PubMed  CAS  Google Scholar 

  • Young JB, Candsberg L, Knopp RH (1976) Effect of intravenous glucagon on urinary catecholamine excretion in normal man. Metabolism 25: 233–237

    Article  PubMed  CAS  Google Scholar 

  • Zicha L, Schmid E, Weist F, Winkler E (1965) Der Einfluß von Glukagon, Insulin, Adrenalin und Sulfonylharnstoffen auf Blutzucker und Vanillinmandelsäure im Harn bei gesunden Kontrollpersonen, Leberkranken und anderen Patienten mit Dysproteinämie. Verh Deutsch Ges Inn Med 71: 499–501

    CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1983 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Lefebvre, P.J., Luyckx, A.S. (1983). Glucagon and Catecholamines. In: Lefebvre, P.J. (eds) Glucagon II. Handbook of Experimental Pharmacology, vol 66 / 2. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-69019-8_29

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-69019-8_29

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-69021-1

  • Online ISBN: 978-3-642-69019-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics